Medindia LOGIN REGISTER
Medindia

Side effect(s) of Niraparib


Review the side-effects of Niraparib as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the instances these side-effects are mild and easily tolerable, however sometimes they can be more severe and can be detrimental.

If the side effects are not tolerable adjusting the dosage or switching to a different medication can help to manage or overcome side effects. If you have any doubts or questions, we recommend seeking advice from your doctor or pharmacist.

  Common:
Fatigue or asthenia, nausea, loss of appetite, insomnia, peripheral edema

  Gastrointestinal:
Dry mouth, problems with taste, dyspepsia, diarrhea, constipation, mucosal inflammation, vomiting, abdominal pain

  Central nervous system:
Dizziness, headache, anxiety, depression

  Cardiovascular system:
Hypertension, palpitations

  Respiratory:
Cough, difficulty in breathing, nasopharyngitis, bronchitis, epistaxis

  Musculoskeletal:
Back pain, arthralgia, muscle pain

  Blood:
Decreased hemoglobin, reduced number of white blood cells or platelets, acute myeloid leukemia

  Others:
Rash, urinary tract infection, elevated levels of liver enzymes

Other Precautions :

• Do not use niraparib capsules prescribed for others or a condition for which it is not prescribed.
• It is necessary to confirm a negative pregnancy test before starting niraparib treatment as the drug may cause harm to the baby.
• In case of a missed dose, the next dose should be taken at the scheduled time.
• Do not take less or double the dose. Take exactly as directed by the treating physician.

Drug Name : Niraparib

Niraparib generic Niraparib is prescribed as a maintenance treatment in adult patients with recurrent epithelial ovarian cancer , fallopian tube cancer, or primary peritoneal cancer who show a complete or partial response to platinum-based chemotherapy. Niraparib works by inhibiting the PARP (poly ADP-ribose polymerase) activity. It results in the formation of PARP-DNA complexes leading to the damage of DNA and tumor cell death. It benefits by improving the patient's progression-free survival and should be given only by the medical specialist who is an expert in handling anti-cancer medicines.


Advertisement